James N. Class, PhD

 
Dr. James N. Class is the Assistant Vice President of International Affairs for the Pharmaceutical Research and Manufacturers of America (PhRMA), the main trade association for the research-based pharmaceutical industry in the United States.  Currently, Dr. Class manages PhRMA’s trade policy in Eastern Europe, Russia and Turkey in addition to handling a variety of intellectual property issues including biosimilars, anti-counterfeiting and regulatory data protection.  Prior to 2007, Dr. Class worked as a liaison between anti-counterfeiting groups and was the Executive Director for the United States’ division of the Partnership for Safe Medicines.

In 2005, Dr. Class worked to coordinate establishing the first direct-to-consumer e-mail alert service on counterfeit drugs, which has since been integrated into the U.S. Food and Drug Administration’s (FDA) Counterfeit Alert Network. In addition, he founded a news update on counterfeit drugs, which is sent out to the FDA, the Drug Enforcement Administration, U.S. Federal Bureau of Investigation, the International Criminal Police Organization (Interpol), local law enforcement agencies, industry and other communities. Currently, Dr. Class participates in the Interpol Intellectual Property Crime Action Group and the World Health Organization’s IMPACT Enforcement Working Group.

Dr. Class is an alumnus of Georgetown University where he received his PhD with honors in 2004.